Dae-kee Kim
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Synthesis, biological evaluation and molecular modelling of 2,4-disubstituted-5-(6-alkylpyridin-2-yl)-1H-imidazoles as ALK5 inhibitors.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: March 14, 2020
Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells.
Journal: Oncotarget
Published: July 31, 2015
EW-7197, a novel ALK-5 kinase inhibitor, potently inhibits breast to lung metastasis.
Journal: Molecular cancer therapeutics
Published: May 13, 2014
An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
Journal: Cancer letters
Published: January 14, 2014
Anti-Cancer Effect of IN-2001 in T47D Human Breast Cancer.
Journal: Biomolecules & therapeutics
Published: October 25, 2011
Anti-Cancer Effect of 3-(4-dimethylamino phenyl)-N-hydroxy-2-propenamide in MCF-7 Human Breast Cancer.
Journal: Environmental health and toxicology
Published: October 25, 2011
Anti-Cancer Effect of IN-2001 in MDA-MB-231 Human Breast Cancer.
Journal: Biomolecules & therapeutics
Published: October 25, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026